Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity
Clinical Kidney Journal · 07.01.2025 · 18 (1)
DOI: 10.1093/ckj/sfae395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 03.12.2024. Verfasst von Mazdak Sanaei Nurmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialist Care, Nephrology Clinic, Danderyd University Hospital, Stockholm, Sweden. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Augustinus Foundation, Stiftelsen Stig och Gunborg Westman, Swedish Society of Medicine.
Abstract (Originalsprache)
Introduction
The activation of the complement system plays an important role in the pathogenesis of IgA nephropathy (IgAN). Our primary aim was to evaluate a range of complement-related proteins, including pentraxin-3 (PTX-3), in blood and urine at diagnosis and their association with disease activity in the kidney biopsy, eGFR, albuminuria, and outcome. Our secondary aim was to compare the same biomarkers between patients with IgAN and IgA vasculitis with renal involvement (IgAVN).
Methods
In a longitudinal Swedish cohort of 96 patients with IgAN (n = 65) or IgAVN (n = 31), with a median follow-up time of 10.8 years, we analysed mainly lectin-pathway-related proteins and PTX-3 in plasma and urine (u) samples stored at the time of kidney biopsy. Outcome was defined by the GFR slope or by the combined outcome of 50% loss of eGFR or end-stage kidney disease (ESKD).
Results
Patients with detectable vs undetectable u-PTX-3 and u-mannose-binding lectin (MBL) more frequently had mesangial hypercellularity, endocapillary proliferation, and crescents in their kidney biopsy. u-C4c levels were higher in patients with advanced tubulointerstitial fibrosis, and u-C4c was also an independent predictor of a more severe eGFR slope. There were no differences in the levels of biomarkers between patients with IgAN and IgAVN. Conclusion u-PTX-3 and u-MBL might be biomarkers of an active proliferative stage of the disease, while higher u-C4c levels indicate more chronic lesions in both IgAN and IgAVN. These results must, however, be confirmed in larger and multiethnic cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Specialist Care, Nephrology Clinic, Danderyd University Hospital, Stockholm, Sweden.
- Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
- Laboratory of Molecular Medicine, Department of Clinical Immunology, Section, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Department of Medical Sciences, Renal Medicine, Uppsala University Hospital, Uppsala, Sweden.
- Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Sigrid Lundberg
Förderung
- Augustinus Foundation
- Stiftelsen Stig och Gunborg Westman
- Swedish Society of Medicine
Zitieren
APA
Nurmi, M. S., Pérez-Alós, L., Garred, P., Fellström, B., Gabrysch, K., & Lundberg, S. (2025). Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity. Clinical Kidney Journal, 18(1). https://doi.org/10.1093/ckj/sfae395
Vancouver
Nurmi MS, Pérez-Alós L, Garred P, Fellström B, Gabrysch K, Lundberg S. Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity. Clinical Kidney Journal. 2025;18(1). doi:10.1093/ckj/sfae395
BibTeX
@article{Nurmi2025,
author = {Nurmi, Mazdak Sanaei and Pérez-Alós, Laura and Garred, Peter and Fellström, Bengt and Gabrysch, Katja and Lundberg, Sigrid},
title = {Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity},
journal = {Clinical Kidney Journal},
year = {2025},
volume = {18},
number = {1},
doi = {10.1093/ckj/sfae395}
}
EUVIMED